DeepMed Research

RTOG Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rtog.org

Clinical Trials

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Phase 3

Active, not recruiting

Conditions: Breast Cancer

Interventions: Radiation: Hypofractionated whole breast irradiation
Radiation: Standard fractionation whole breast irradiation
Radiation: Sequential boost
Radiation: Concurrent boost

First Posted Date: 2011-05-06

Last Posted Date: 2023-04-06

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 2354

Registration Number: NCT01349322

Locations: 🇺🇸
University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸
Texas Oncology - Denison Cancer Center, Denison, Texas, United States
🇺🇸
Northside Hospital, Atlanta, Georgia, United States

and more 412 locations

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Phase 3

Active, not recruiting

Conditions: Head and Neck Cancer
Precancerous Condition

Interventions: Biological: cetuximab
Drug: cisplatin
Radiation: IMRT

First Posted Date: 2011-02-24

Last Posted Date: 2024-10-28

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 987

Registration Number: NCT01302834

Locations: 🇺🇸
John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States
🇺🇸
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center, Burbank, California, United States
🇺🇸
Radiation Oncology Centers - Cameron Park, Cameron Park, California, United States

and more 181 locations

Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Biological: ganitumab
Drug: capecitabine
Drug: gemcitabine hydrochloride
Radiation: 3-dimensional conformal radiation therapy

First Posted Date: 2011-02-17

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 8

Registration Number: NCT01298401

Locations: 🇺🇸
CCOP - Christiana Care Health Services, Newark, Delaware, United States
🇺🇸
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States

and more 7 locations

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Phase 2

Completed

Conditions: Dysphagia
Lung Cancer
Pain
Esophagitis

Interventions: Drug: Standard supportive care
Drug: Manuka honey in liquid form
Drug: Manuka honey in lozenge form

First Posted Date: 2010-12-17

Last Posted Date: 2017-08-31

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 163

Registration Number: NCT01262560

Locations: 🇺🇸
University of Texas Medical Branch, Galveston, Texas, United States
🇺🇸
York Cancer Center at Apple Hill Medical Center, York, Pennsylvania, United States
🇺🇸
Parkview Regional Cancer Center at Parkview Health, Fort Wayne, Indiana, United States

and more 56 locations

Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase 2

Completed

Conditions: Cognitive/Functional Effects
Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Radiation: intensity-modulated radiation therapy

First Posted Date: 2010-10-25

Last Posted Date: 2017-09-27

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 113

Registration Number: NCT01227954

Locations: 🇺🇸
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Arizona Center for Cancer Care - Peoria, Peoria, Arizona, United States

and more 60 locations

Radiation Therapy with or Without Chemotherapy in Treating Patients with High-Risk Malignant Salivary Gland Tumors That Have Been Removed by Surgery

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Radiation: 3-dimensional conformal radiation therapy
Radiation: intensity-modulated radiation therapy

First Posted Date: 2010-10-14

Last Posted Date: 2025-02-13

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 252

Registration Number: NCT01220583

Locations: 🇺🇸
Arizona Center for Cancer Care-Surprise, Surprise, Arizona, United States
🇺🇸
University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
🇺🇸
Banner University Medical Center - Tucson, Tucson, Arizona, United States

and more 265 locations

Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Phase 3

Completed

Conditions: Lung Cancer

Interventions: Drug: Cisplatin
Drug: Etoposide
Drug: Vinblastine
Radiation: Radiation therapy

First Posted Date: 2010-06-02

Last Posted Date: 2015-03-27

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 610

Registration Number: NCT01134861

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Radiation: 3D-Conformal External Beam

First Posted Date: 2010-03-08

Last Posted Date: 2022-06-21

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 65

Registration Number: NCT01082211

Locations: 🇺🇸
William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States
🇺🇸
Summa Center for Cancer Care at Akron City Hospital, Akron, Ohio, United States
🇺🇸
Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States

and more 55 locations

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: concurrent RAD001 10 mg/day
Drug: concurrent temozolomide
Radiation: Radiation therapy
Drug: concurrent RAD001 2.5 mg/day
Drug: concurrent RAD001 5 mg/day
Drug: post-radiation RAD001 10 mg/day
Drug: post-radiation temozolomide

First Posted Date: 2010-02-04

Last Posted Date: 2022-06-09

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 279

Registration Number: NCT01062399

Locations: 🇺🇸
St. Barnabas Medical Center Cancer Center, Livingston, New Jersey, United States
🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸
St. Agnes Hospital Cancer Center, Baltimore, Maryland, United States

and more 33 locations

Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Radiation: Prophylactic Cranial Irradiation
Radiation: Radiation Therapy

First Posted Date: 2010-01-25

Last Posted Date: 2018-12-12

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 97

Registration Number: NCT01055197

Locations: 🇺🇸
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, New Britain, Connecticut, United States
🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Integrated Community Oncology Network at Southside Cancer Center, Jacksonville, Florida, United States

and more 112 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy